肝硬化中血清氨水平检测的持续争议:优势、劣势与难点
该文综述肝性脑病(HE)中血清氨检测的争议,指出尽管氨在HE病理生理中居核心地位,但实验室采集与解读复杂;各指南对常规检测意见不一,但均认为HE时氨正常值可能需重新考虑诊断。作者提出根据验前概率分层检测:高或低验前概率时氨检测附加价值小,验前概率不确定时低氨水平可降低HE验后概率,并应探索其他意识改变病因。未来需标准化氨的采集、处理和解读。
要点
- 高或低验前概率时,血清氨检测附加获益很小。
- 验前概率不确定时,低氨水平可降低HE验后概率。
- HE时氨正常值可能需重新考虑诊断。
核心结论
- 血清氨检测在高或低验前概率的临床场景中附加获益很小,在验前概率不确定时低氨水平可降低HE验后概率。
研究设计与样本
- 本文为综述,检索范围未在摘要中报告。
主要发现
- 各指南组织对HE常规氨检测存在分歧,但均承认HE时氨正常值可能需重新考虑诊断。
- 验前概率高或低时,血清氨检测提供很少附加获益。
- 验前概率不确定时,低氨水平可降低HE验后概率,此时应探索其他意识改变病因。
临床怎么用
- 作者提出根据验前概率分层检测:高或低验前概率时氨检测附加获益小;验前概率不确定时低氨水平可降低HE验后概率。
局限性
- 未来研究应聚焦于建立血清氨采集、处理和解读的标准化方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Serum ammonia testing in hepatic encephalopathy (HE) has been long debated in the field of hepatology. Although central to the pathophysiology of HE, serum ammonia testing is fraught with complexities that can lead to challenges in laboratory collection and interpretation. Although there is some disagreement across guideline organizations regarding routine testing of ammonia in HE, all acknowledge that normal values, although possible in HE, may warrant reconsideration of the diagnosis. In this study, we propose a nuanced approach to ammonia testing in HE. Serum ammonia testing provides little additional benefit in clinical scenarios with a high or low pretest probability for HE. However, if the pretest probability for HE is uncertain, a low ammonia level may reduce the posttest probability of HE. In this scenario, other etiologies of altered mental status should be explored. Future research should focus on developing a standardized approach to serum ammonia collection, processing, and interpretation.
引用
- Deutsch-Link S, Moon AM. The Ongoing Debate of Serum Ammonia Levels in Cirrhosis: the Good, the Bad, and the Ugly. Am J Gastroenterol. 2022. PMID: 36001400. doi:10.14309/ajg.0000000000001966
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。